RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TARAMASSO L
Collezione ASL Città di Torino

Items : 28

Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2025 Mar 3;80(3):610-623. doi: 10.1093/jac/dkaf025.

2025
ASL Città di Torino

Lo Caputo S; Guaraldi G; Gianotti N; Di Biagio A; Cingolani A; Bonora S; Taramasso L; Madeddu G; Maggi P; Marchetti G; Nozza S; Rusconi S; Maggiolo F;

Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process. in The new microbiologica / New Microbiol. 2024 Jan;46(4):367-380.

2024
ASL Città di Torino

Maggiolo F; Lo Caputo S; Bonora S; Borderi M; Cingolani A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Gervasoni C; Guaraldi G; Maggi P; Taramasso L;

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study. in Viruses / Viruses. 2024 Apr 15;16(4):613. doi: 10.3390/v16040613.

2024
AOU Alessandria
ASL Città di Torino
AOU Novara

Bargiacchi O; Ricci ED; Angioni G; Guadagnino G; Martini S; Falasca K; Ferrara S; Carleo MA; Maggi P; Cenderello G; Bandera A; Calza L; Sarchi E; Gulminetti R; Celesia BM; Cascio A; Pontali E; Bellagamba R; Pellicanò GF; Madeddu G; Salomoni E; De Socio GV; Molteni C; Taramasso L; Di Biagio A; Lagi F; Squillace N; Guastavigna M; Orofino G; et alii...

Pillars of long-term antiretroviral therapy success. in Pharmacological research / Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.

2023
ASL Città di Torino

Taramasso L; Andreoni M; Antinori A; Bandera A; Bonfanti P; Bonora S; Borderi M; Castagna A; Cattelan AM; Celesia BM; Cicalini S; Cingolani A; Cossarizza A; D'Arminio Monforte A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Di Perri G; Esposito V; Focà E; Gervasoni C; Gori A; Gianotti N; Guaraldi G; Gulminetti R; Lo Caputo S; Madeddu G; Maggi P; Marandola G; et alii...

Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study. in Viruses / Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720.

2023
AOU Alessandria
ASL Città di Torino

Di Biagio A; Falasca K; Cenderello G; Cascio A; Sarchi E; Pellicanò GF; Parruti G; Celesia BM; Costa C; Valsecchi L; Molteni C; De Socio GV; Squillace N; Taramasso L; Orofino G; Martinelli CV; Ricci E; Menzaghi B; De Vito A; Bonfanti P; Madeddu G;

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. in Viruses / Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612.

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Bonfanti P; Di Biagio A; Cenderello G; Ferrara S; Falasca K; Bargiacchi O; Martini S; Sarchi E; Calza L; Rusconi S; Valsecchi L; Parisini A; Taramasso L; Carleo MA; Cascio A; Pellicanò GF; Madeddu G; Celesia BM; Vichi F; Bellagamba R; Orofino G; Menzaghi B; Masiello A; Molteni C; Squillace N; De Socio GV; Ricci ED; Martinelli CV; Maggi P; et alii...

Incident diabetes in course of antiretroviral therapy. in AIDS (London, England) / AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14.

2023
AOU Alessandria
ASL Città di Torino

Gulminetti R; Sarchi E; Cascio A; Pellicanò GF; Maggi P; Rusconi S; Celesia BM; Valsecchi L; Vichi F; Madeddu G; Martinelli CV; Socio GV; Molteni C; Orofino G; Ricci E; Menzaghi B; Squillace N; Taramasso L; Falasca K; Di Biagio A; Bonfanti P;

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens. in BMC infectious diseases

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Bonfanti P; Di Biagio A; Falasca K; Taramasso L; Menzaghi B; Molteni C; Masiello A; Saracino A; Bargiacchi O; De Socio GV; Squillace N; Madeddu G; Sarchi E; Orofino G; Cascio A; Celesia BM; Vichi F; Pellicanò GF; Cicalini S; Maggi P; Ricci ED;

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir. in PloS one / PLoS One. 2023 Aug 9;18(8):e0289132. doi: 10.1371/journal.pone.0289132. eCollection 2023.

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Di Biagio A; Bargiacchi O; Cascio A; Angioni G; Falasca K; Attala L; Cenderello G; Bandera A; Valsecchi L; Simeone F; Pellicanò GF; Sarchi E; Piconi S; Maurizio Celesia B; Orofino G; De Socio GV; Taramasso L; Menzaghi B; Bonfanti P; Maggi P; Ricci E; Squillace N;

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? in BMC infectious diseases / BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y.

2022
AOU Alessandria
ASL Città di Torino

Falasca K; Calza L; Parisini A; Cenderello G; Gulminetti R; Valsecchi L; Celesia BM; Martinelli CV; Pellicanò G; Sarchi E; Vichi F; Cascio A; Madeddu G; Gamboni G; Guastavigna M; Taramasso L; Molteni C; Squillace N; Menzaghi B; De Socio GV; Maggi P; Orofino G; Ricci E; Di Biagio A; Bonfanti P;

Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study. in Viruses / Viruses. 2022 Oct 22;14(11):2315. doi: 10.3390/v14112315.

2022
AOU Alessandria
ASL Città di Torino

Celesia BM; Vichi F; Sarchi E; Madeddu G; Gulminetti R; Molteni C; Pellicanò GF; De Socio GV; Menzaghi B; Squillace N; Ricci E; Orofino G; Falletta A; Taramasso L; Bonfanti P; Di Biagio A;

Reversibility of Central Nervous System Adverse Events in Course of Art. in Viruses / Viruses. 2022 May 11;14(5):1028. doi: 10.3390/v14051028.

2022
AOU Alessandria
ASL Città di Torino

Grosso C; Cascio A; Angioni G; Sarchi E; Del Puente F; Conti F; Molteni C; Celesia BM; Vichi F; Madeddu G; Squillace N; De Socio GV; Menzaghi B; Ricci E; Orofino G; Taramasso L; Parruti G; Di Biagio A; Bonfanti P;

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade. in HIV medicine / HIV Med. 2022 Jan;23(1):70-79. doi: 10.1111/hiv.13165. Epub 2021 Sep 2.

2022
ASL Città di Torino

Taramasso L; Bonfanti P; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Molteni C; Vichi F; Riguccini E; Saracino A; Santoro C; Guastavigna M; Francisci D; Di Biagio A; De Socio GV;

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. in AIDS patient care and STDs / AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089.

2021
AOU Alessandria
ASL Città di Torino

Dentone C; Bandera A; Cenderello G; Guadagnino G; Angioni G; Vichi F; Maggi P; Cascio A; Martinelli CV; Valsecchi L; Rusconi S; Calza L; Celesia BM; Sarchi E; Pellicanò GF; De Socio GV; Gulminetti R; Molteni C; Menzaghi B; Squillace N; Ricci ED; Orofino G; Taramasso L; De Vito A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.

2020
ASL Città di Torino

Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

Factors associated with hospital admission for COVID-19 in HIV patients. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663.

2020
ASL Città di Torino
AOU Novara

Falasca K; Maggi P; Saracino A; Ferrara S; Cenderello G; Valsecchi L; Molteni C; Bargiacchi O; Orofino G; Rusconi S; Menzaghi B; Squillace N; Calza L; Ricci E; Di Biagio A; Taramasso L; Bonfanti P;

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study. in BMC public health / BMC Public Health. 2020 May 20;20(1):734. doi: 10.1186/s12889-020-08862-8.

2020
ASL Città di Torino

De Socio GV; Pasqualini M; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Taramasso L; Francisci D; Bonfanti P; Vichi F; dell'Omo M; Pieroni L;

Factors Associated With Weight Gain in People Treated With Dolutegravir. in Open forum infectious diseases / Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun.

2020
AOU Alessandria
ASL Città di Torino

Dentone C; Vichi F; Maggi P; Bolla C; Cascio A; Valsecchi L; Martinelli CV; Conti F; Calza L; Celesia BM; Pagnucco L; Pellicanò GF; Madeddu G; De Socio GV; Menzaghi B; Squillace N; Orofino G; Ricci E; Bonfanti P; Taramasso L; Angioni G; Mastroianni A; Falasca K; Cenderello G; Di Biagio A;

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.

2019
ASL Città di Torino
AOU Novara

Monno L; Callegaro AP; Paolini E; Zoncada A; Pecorari M; Francisci D; Borghi V; Galli L; Vicenti I; Bruzzone B; Taramasso L; Ungaro R; Bonora S; Di Biagio A;

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project. in Infection and drug resistance / Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019.

2019
ASL Città di Torino

Bagella P; Squillace N; Ricci E; Gulminetti R; De Socio GV; Taramasso L; Pellicanò G; Menzaghi B; Celesia BM; Dentone C; Orofino G; Bonfanti P; Madeddu G;

First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. in HIV medicine / HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.

2018
ASL Città di Torino

Taramasso L; Di Biagio A; Maggiolo F; Tavelli A; Lo Caputo S; Bonora S; Zaccarelli M; Caramello P; Costantini A; Viscoli C; d'Arminio Monforte A; Cozzi-Lepri A;

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? in The Journal of allergy and clinical immunology / J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov

2018
ASL Città di Torino

Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G;

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). in BMC infectious diseases / BMC Infect Dis. 2018 Jul 31;18(1):357. doi: 10.1186/s12879-018-3268-5.

2018
ASL Città di Torino

Taramasso L; Tatarelli P; Ricci E; Madeddu G; Menzaghi B; Squillace N; De Socio GV; Martinelli C; Gulminetti R; Maggi P; Orofino G; Vichi F; Di Biagio A; Bonfanti P;

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.

2018
ASL Città di Torino

Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Sollima S; Gubertini G; Niero F; Saracino A; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Mastroianni C; Di Perri G; Bigoni S; Puoti M; Spinetti A; Gori A; Boffa N; Cacopardo B; Giacometti A; Parruti G; Vullo V; Chirianni A; et alii...

Weight Gain: A Possible Side Effect of All Antiretrovirals. in Open forum infectious diseases / Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239. doi: 10.1093/ofid/ofx239. eCollection 2017 Fall.

2017
ASL Città di Torino

Taramasso L; Ricci E; Menzaghi B; Orofino G; Passerini S; Madeddu G; Martinelli CV; De Socio GV; Squillace N; Rusconi S; Bonfanti P; Di Biagio A;

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells. in Journal of virology / J Virol. 2017 Nov 14;91(23):e00647-17. doi: 10.1128/JVI.00647-17. Print 2017 Dec 1.

2017
ASL Città di Torino

Marras F; Casabianca A; Bozzano F; Ascierto ML; Orlandi C; Di Biagio A; Pontali E; Dentone C; Orofino G; Nicolini L; Taramasso L; Magnani M; Marincola FM; Wang E; Moretta L; De Maria A;

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study. in Infection / Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.

2016
ASL Città di Torino

De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P;

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12.

2015
ASL Città di Torino

Taramasso L; Madeddu G; Ricci E; De Socio GV; Menzaghi B; Orofino G; Passerini S; Franzetti M; Maggi P; Dentone C; Martinelli C; Celesia BM; Penco G; Libertone R; Quirino T; Bonfanti P; Di Biagio A;